Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/ced/llad387 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Case report: Toxic epidermal necrolysis induced by tislelizumab in a patient with esophageal squamous cell carcinoma.
Front Med (Lausanne)
December 2024
Department of Oncology, Ganzhou People's Hospital, Ganzhou, China.
Background: Immune checkpoint inhibitors (ICIs) have been widely applicated for the treatment of patients with advanced esophageal cancer. Skin-related adverse reactions are frequent with ICIs, with toxic epidermal necrolysis (TEN) being a severe and potentially life-threatening cutaneous reaction.
Case Presentation: We present a case of a 70-year-old male with locally advanced esophageal cancer who developed severe toxic epidermal necrolysis (TEN) after 18 days of tislelizumab combined with chemotherapy.
There are no good evidence-based recommendations for any systemic treatment of erosive lichen planus (ELP). Extracorporeal photopheresis (ECP) may be an effective therapy for recalcitrant forms of the disease. We report 3 patients with severe ELP treated with ECP.
View Article and Find Full Text PDFAcne vulgaris affects approximately 80% of young adults and adolescents in the world. Acne presents as comedones, pustules, papules, and nodules on the face, chest, shoulders, or back. It can lead to a significant decrease in quality of life with a high risk of associated depression and anxiety.
View Article and Find Full Text PDFOral Antibiotics and Cutaneous Adverse Drug Reactions-Reply.
JAMA
January 2025
Division of General Internal Medicine and Clinical Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.
Oral Antibiotics and Cutaneous Adverse Drug Reactions.
JAMA
January 2025
Department of Clinical and Environmental Allergology, Jagiellonian University Medical College, Kraków, Poland.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!